Wellesley, MA, United States of America

John Evenden


Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 15(Granted Patents)


Location History:

  • Stockholm, SE (1999)
  • Wellesley, MA (US) (2001)

Company Filing History:


Years Active: 1999-2001

Loading Chart...
5 patents (USPTO):Explore Patents

Title: John Evenden: Innovator in Pharmaceutical Composition

Introduction

John Evenden is a notable inventor based in Wellesley, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of affective disorders. With a total of 5 patents to his name, Evenden's work focuses on innovative compositions and methods that address various mental health conditions.

Latest Patents

Evenden's latest patents include groundbreaking compositions for the treatment of 5-HT-mediated disorders. One of his inventions involves a composition comprising a first component, (R)-3N,N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide hydrogen (2R,3R)-tartrate monohydrate, and a second component, 1-[3-(dimethylamino)propyl]-1-(p-fluorophenyl)-5-phthalancarbonitrile. This invention not only details the composition but also outlines the preparation methods, pharmaceutical formulations, and treatment methods for mood and anxiety disorders. Another patent similarly focuses on a composition with (R)-5-carbamoyl-8-fluoro-3-N,N-dicyclobutylamino-3,4-dihydro-2H-1-benzopyran and its applications in treating affective disorders.

Career Highlights

John Evenden is currently associated with Astra Aktiebolag, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing new treatments that enhance the quality of life for individuals suffering from mental health issues.

Collaborations

Evenden collaborates with fellow innovator Seth-Olov Thorberg, contributing to the advancement of pharmaceutical research and development.

Conclusion

John Evenden's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving mental health treatment. His work continues to pave the way for new therapeutic options in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…